Castle Biosciences officer plans $841K share sale
CASTLE BIOSCIENCES INC (CSTL) received a Rule 144 notice indicating a proposed sale of common stock for the account of officer Kristen M. Oelschlager, with J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CASTLE BIOSCIENCES INC (CSTL) received a Rule 144 notice indicating a proposed sale of common stock for the account of officer Kristen M. Oelschlager, with J.P. Morgan Securities LLC acting as agent and attorney-in-fact. The filing covers a proposed sale of 24,602 shares of common stock, with an indicated aggregate market value of $841,388.40. The notice states that the shares are held by The Fritz Shorter Trust, with Kristen and Michael Oelschlager as trustees, and were associated with an account retitled into the trust name on March 19, 2025. The issuer reports 30,549,507 shares of common stock outstanding as of the filing context.
Key Figures
Key Terms
Rule 144 regulatory
aggregate market value financial
attorney-in-fact regulatory
trustees financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for CSTL?
Which broker is handling the proposed CSTL Rule 144 sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.